%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png){kind=logo}
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于药石转债预计满足赎回条件的提示性公告 | 2025-08-07 | Chinese | |
| 信息披露暂缓与豁免业务管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 防范控股股东及关联方占用公司资金管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 董事、高级管理人员持有和买卖本公司股票管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 董事会议事规则（2025年8月） | 2025-08-07 | Chinese | |
| 独立董事专门会议工作制度（2025年8月） | 2025-08-07 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40024115 | 关于药石转债预计满足赎回条件的提示性公告 | 2025-08-07 | Chinese | ||
| 40024103 | 信息披露暂缓与豁免业务管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024081 | 防范控股股东及关联方占用公司资金管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024069 | 董事、高级管理人员持有和买卖本公司股票管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024057 | 董事会议事规则（2025年8月） | 2025-08-07 | Chinese | ||
| 40024049 | 独立董事专门会议工作制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024036 | 重大信息内部报告制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024027 | 关于公司股东减持股份的预披露公告 | 2025-07-10 | Chinese | ||
| 40024018 | 关于公司董事减持股份的预披露公告 | 2025-07-03 | Chinese | ||
| 40023974 | 关于2025年第二季度可转债转股情况的公告 | 2025-07-02 | Chinese | ||
| 40023972 | 南京药石科技股份有限公司相关债券2025年跟踪评级报告 | 2025-06-23 | Chinese | ||
| 40023968 | 关于参股公司在香港联交所主板挂牌上市的公告 | 2025-06-23 | Chinese | ||
| 40023954 | 南京药石科技股份有限公司向不特定对象发行可转换公司债券受托管理事务报告（2024年度） | 2025-06-19 | Chinese | ||
| 40023951 | 关于药石转债恢复转股的提示性公告 | 2025-05-29 | Chinese | ||
| 40023941 | 关于2024年年度权益分派调整可转债转股价格的公告 | 2025-05-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.